11056-06-7
- Product Name:Bleomycin
- Molecular Formula:C110H168N34O46S7
- Purity:99%
- Molecular Weight:2927.17
Product Details:
CasNo: 11056-06-7
Molecular Formula: C110H168N34O46S7
Appearance: White to off-white Powder
Packing: Bottle
Throughput: 10KG/Month
Purity: 99%
Bleomycin is indicated for palliative treatment of malignancies, as single‑agent or combination chemotherapy:
- Squamous cell carcinoma:Squamous cell carcinoma of head‑and‑neck, cervix, vulva, penis, skin.
- Lymphomas:Hodgkin’s disease, non‑Hodgkin’s lymphoma.
- Testicular carcinoma:Embryonal‑cell carcinoma, choriocarcinoma, teratocarcinoma.
- Malignant pleural effusion:As sclerosing agent for treatment and prevention of recurrent malignant pleural effusion via intra‑pleural administration.
Product Name: Bleomycin Sulfate
CAS No: 11056‑06‑1
Category: Cytotoxic Antitumor Antibiotic API
Source: Fermentation product from Streptomyces verticillus, main components Bleomycin A₂ and Bleomycin B₂.
Mechanism of Action: Induces DNA strand breakage, inhibits DNA synthesis of tumor cells; cell‑cycle non‑specific cytotoxic agent.
Appearance: White or off‑white lyophilized powder.
Solubility: Freely soluble in water; practically insoluble in organic solvents.
Storage: Store sealed, protected from light, 2‑8℃.
Warning: Cytotoxic substance; handle with proper PPE. Pulmonary toxicity is major risk in clinical use.
Relevant Products
-
Sparsentan
CAS:254740-64-2
-
Dorzolamide
CAS:120279-96-1
-
O-304
CAS:1261289-04-6





